PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
NCT02039960
·
clinicaltrials.gov ↗
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder, Major
Interventions
DRUG:
Bupropion
Sponsor
GlaxoSmithKline